.Pharmacolibrary.Drugs.C_CardiovascularSystem.C10A_LipidModifyingAgentsPlain.C10AB02_Bezafibrate.Bezafibrate .Pharmacolibrary.Drugs.C_CardiovascularSystem.C10A_LipidModifyingAgentsPlain.C10AB02_Bezafibrate.Bezafibrate| name: | Bezafibrate | |
| ATC code: | C10AB02 | route: | oral |
| compartments: | 1 | |
| dosage: | 400 | mg |
| volume of distribution: | 17 | L |
| clearance: | 7.2 | L/h |
| other parameters in model implementation | ||
Bezafibrate is a lipid-lowering agent belonging to the fibrate class, used for the treatment of hyperlipidemia and hypertriglyceridemia. It acts as a peroxisome proliferator-activated receptor (PPAR) agonist, reducing cholesterol and triglyceride levels. Bezafibrate is approved and used clinically for the management of dyslipidemia.
Pharmacokinetic parameters reported in healthy adult volunteers after single oral administration.
Ali, O, et al., & Ahmed, SW (2002). Bioavailability study of tablet Bezafibrate 200 mg (Lipocor). Pakistan journal of pharmaceutical sciences 15(1) 35–42. PUBMED:https://pubmed.ncbi.nlm.nih.gov/16414866